Experience the innovative spirit of the most promising Swiss startups and prepare to be inspired as they redefine what’s possible.
From longevity and preventive wellness to next-generation wearables and the future of pharma, the next wave of health innovation is being built right now.
Together with Innosuisse, Swissnex invites you to an exclusive Next-Gen Health Pitch Night, the highlight of a two-week Startup Camp that has helped scale global success stories like MindMaze, Scandit, and Beekeeper.
Meet five ambitious Swiss startups pushing the boundaries of human health and performance: Bewe, Oncobit, Optohive, Terapet and Topadur.
Bewe
Oncobit
Optohive
Terapet
Topadur
Speaker
Adrian received his PhD in the laboratory of Prof. Donald Hilvert at the Swiss Federal Institute of Technology Zurich (ETH Zurich, Switzerland), where he gained foundational experience in enzymology, antibody engineering, and directed evolution. Motivated by a strong interest in protein engineering, he then joined the laboratory of Prof. Dan Tawfik at the Weizmann Institute of Science (Israel), where he investigated molecular evolution and its applications in protein design.
Adrian Hugenmatter subsequently worked for more than a decade at Roche as a research scientist and team leader. During this time, he contributed to the development and optimization of multiple antibody lead candidates for therapeutic applications in neuroscience and oncology.
Throughout his career, Adrian has been driven by the goal of developing medicines that provide the greatest possible benefit to patients. At Stanford, he also leads the Protein Engineering Knowledge Center at Sarafan ChEM-H. At both Sarafan ChEM-H and the Institute for Molecular and Cellular Biology (IMA), he and his team collaborate with principal investigators across Stanford to accelerate drug discovery based on pioneering scientific discoveries.
Speaker
Amanda has deep experience as an investor in the healthcare industry. She began her career in private equity on Carlyle’s healthcare team and later expanded into venture capital and the public markets. Most recently, she led MedTech investing at Farallon Capital Management while also serving as a Board Director at Beta Bionics. She holds an A.B. in Applied Mathematics and an M.B.A. from Harvard University.
Speaker
Working in venture capital for over seven years has given Daniela a clear perspective on two core priorities: first, identifying the most promising startups to generate strong fund returns; and second, delivering strategic value to investors and LPs by ensuring alignment with corporate strategy and leveraging technology and innovation to drive growth. She understands that deep market insight is essential for achieving top-line revenue growth, especially during times of disruption.
Daniela is passionate about staying at the forefront of technology by advising LPs and Global Fortune 500/2000 corporations on integrating and investing in transformative solutions, while also supporting startups as they scale. As a network builder, she connects individuals and organizations to foster knowledge sharing and advance strategic business initiatives.
Daniela brings more than 17 years of experience in international business strategy and development, operations, strategic partnerships, and scaling startups from stealth mode to hypergrowth. She has launched products in over 27 countries and has worked on the regulation of digital products in collaboration with governments, lobbying groups, and both private and state-owned enterprises across Europe. Her Silicon Valley experience includes joining the cybersecurity startup Area 1 Security at an early stage, where she helped drive expansion and growth strategy; the company was acquired by Cloudflare in 2022.
During her time at leading early-stage European VC Speedinvest, Daniela helped launch a new platform strategy and advised European companies on entering the U.S. market. Driven by a strong commitment to supporting founders, she also serves as a mentor at Intel, German Accelerator, and GACC West, where she helps emerging and established tech startups with U.S. market entry, fundraising, go-to-market strategy, and enterprise sales.
The pitch night is part of the Startup Camp (Next-Gen Health), powered by Innosuisse and managed by Swissnex.
